Skip to contentpdufa.bio

MN-001 (tipelukast)

Page updated ·next FDA decision on the calendar ·Data as of Nov 19, 2026 12:24 AM ET

MN-001 (tipelukast) is a Medicinova Inc program. Its next catalyst is a Readout in Dec 2026.

MNOV catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Medicinova Inc (MNOV). We track 1 catalyst event for this program: 1 upcoming and 0 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Dec 2026MNOV

Questions

When is MN-001 (tipelukast)'s next FDA decision or readout?

The next tracked catalyst for MN-001 (tipelukast) is a Readout in Dec 2026.

What happened at MN-001 (tipelukast)'s most recent FDA decision?

No FDA decision for MN-001 (tipelukast) is in our archive yet.

Who makes MN-001 (tipelukast)?

Medicinova Inc (MNOV).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings. Each FDA decision links its own page, which names its source or says plainly that it has none.